메뉴 건너뛰기




Volumn 33, Issue 4, 2011, Pages 393-397

Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration

Author keywords

Continuous hemofiltration; Critically ill; Pharmacokinetic; Renal replacement; Voriconazole

Indexed keywords

VORICONAZOLE;

EID: 80051790646     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3182205d93     Document Type: Article
Times cited : (24)

References (18)
  • 1
    • 33745632766 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic profile of voriconazole
    • DOI 10.2165/00003088-200645070-00002
    • Theuretzbacher U, Ihle F, Derendorf H. Pharmacokinetic/pharmacodynamic profile of voriconazole. Clin Pharmacokinet. 2006;45:649-663. (Pubitemid 43990568)
    • (2006) Clinical Pharmacokinetics , vol.45 , Issue.7 , pp. 649-663
    • Theuretzbacher, U.1    Ihle, F.2    Derendorf, H.3
  • 3
    • 39449117139 scopus 로고    scopus 로고
    • Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
    • DOI 10.1086/524669
    • Pascual A, Calandra T, Bolay S, et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis. 2008;46:201-211. (Pubitemid 351269158)
    • (2008) Clinical Infectious Diseases , vol.46 , Issue.2 , pp. 201-211
    • Pascual, A.1    Calandra, T.2    Bolay, S.3    Buclin, T.4    Bille, J.5    Marchetti, O.6
  • 7
    • 77952594210 scopus 로고    scopus 로고
    • Pharmacokinetics of sulfobutylether-beta-cyclodextrin (SBECD) and voriconazole in patients with endstage renal failure during treatment with two hemodialysis systems and hemodiafiltration
    • Hafner V, Czock D, Burhenne J, et al. Pharmacokinetics of sulfobutylether-beta-cyclodextrin (SBECD) and voriconazole in patients with endstage renal failure during treatment with two hemodialysis systems and hemodiafiltration. Antimicrob Agents Chemother. 2010;54:2596-2602.
    • (2010) Antimicrob Agents Chemother , vol.54 , pp. 2596-2602
    • Hafner, V.1    Czock, D.2    Burhenne, J.3
  • 8
    • 33749639796 scopus 로고    scopus 로고
    • Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy
    • von Mach MA, Burhenne J, Weilemann LS. Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy. BMC Clin Pharmacol. 2006;6:6.
    • (2006) BMC Clin Pharmacol , vol.6 , pp. 6
    • Von MacH, M.A.1    Burhenne, J.2    Weilemann, L.S.3
  • 11
    • 38549162273 scopus 로고    scopus 로고
    • The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient
    • DOI 10.1097/FTD.0b013e31815c1672, PII 0000769120080200000020
    • Quintard H, Papy E, Massias L, et al. The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient. Ther Drug Monit. 2008;30:117-119. (Pubitemid 351161110)
    • (2008) Therapeutic Drug Monitoring , vol.30 , Issue.1 , pp. 117-119
    • Quintard, H.1    Papy, E.2    Massias, L.3    Lasocki, S.4    Arnaud, P.5    Desmonts, J.-M.6    Montravers, P.7
  • 13
    • 0034815124 scopus 로고    scopus 로고
    • Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients
    • DOI 10.1034/j.1399-6576.2001.450802.x
    • Bugge JF. Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiol Scand. 2001;45:929-934. (Pubitemid 32912336)
    • (2001) Acta Anaesthesiologica Scandinavica , vol.45 , Issue.8 , pp. 929-934
    • Bugge, J.F.1
  • 14
    • 35848960092 scopus 로고    scopus 로고
    • Drug dosing in continuous renal replacement therapy: General rules
    • DOI 10.1097/MCC.0b013e3282f0a3d3, PII 0007519820071200000004
    • Schetz M. Drug dosing in continuous renal replacement therapy: general rules. Curr Opin Crit Care. 2007;13:645-651. (Pubitemid 350059527)
    • (2007) Current Opinion in Critical Care , vol.13 , Issue.6 , pp. 645-651
    • Schetz, M.1
  • 15
    • 69549119700 scopus 로고    scopus 로고
    • Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill
    • Kortgen A, Paxian M, Werth M, et al. Prospective assessment of hepatic function and mechanisms of dysfunction in the critically ill. Shock. 2009;32: 358-365.
    • (2009) Shock , vol.32 , pp. 358-365
    • Kortgen, A.1    Paxian, M.2    Werth, M.3
  • 16
    • 69549131096 scopus 로고    scopus 로고
    • Acute liver injury and biomarkers: A biological lesson from indocyanine green
    • Krouzecky A, Radermacher P, Matejovic M. Acute liver injury and biomarkers: a biological lesson from indocyanine green. Shock. 2009;32: 340-341.
    • (2009) Shock , vol.32 , pp. 340-341
    • Krouzecky, A.1    Radermacher, P.2    Matejovic, M.3
  • 17
    • 34247558084 scopus 로고    scopus 로고
    • Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes
    • DOI 10.1016/j.bcp.2007.03.012, PII S0006295207001803
    • Murayama N, Imai N, Nakane T, et al. Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes. Biochem Pharmacol. 2007;73:2020-2026. (Pubitemid 46677908)
    • (2007) Biochemical Pharmacology , vol.73 , Issue.12 , pp. 2020-2026
    • Murayama, N.1    Imai, N.2    Nakane, T.3    Shimizu, M.4    Yamazaki, H.5
  • 18
    • 77955154715 scopus 로고    scopus 로고
    • Review of the basic and clinical pharmacology of sulfobutylether-beta- cyclodextrin (SBECD)
    • Luke DR, Tomaszewski K, Damle B, et al. Review of the basic and clinical pharmacology of sulfobutylether-beta-cyclodextrin (SBECD). J Pharm Sci. 2010;99:3291-3301.
    • (2010) J Pharm Sci , vol.99 , pp. 3291-3301
    • Luke, D.R.1    Tomaszewski, K.2    Damle, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.